About The Author

Editorial & Columns

Product Portfolio of Top Indian Pharmaceutical Companies

January 15, 2025 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

FY24 Review: Attrition and Employee Turnover in Top Indian Pharmaceutical Companies

January 2, 2025 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Metamorphosis : Jan Aushadhi Scheme to PMBJP

December 26, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Pricing of Patented Drugs in India: Balancing the Interests of Patent Holders and Patients

December 21, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

A Brief History of Drug Price Control in India  

December 11, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

AI-focused Partnerships of Global Pharmaceutical Companies

December 5, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Indian Pharmaceutical Industry in Consolidation Mode

November 27, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Cultivating Intrapreneurship: Lessons from Leading Pharmaceutical Companies

November 21, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Monitoring Prices, Availability, Accessibility & Affordability of Medicines-Role of PMRUs

November 14, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Pharmapreneurs in India and their Career Transition

November 6, 2024 | Dr. Anil Kumar Angrish | No Comments |

More